SEC Tracker
Get the app

Homology Medicines QTTB

Homology Medicines: signs a material agreement, sells unregistered shares and 2 other items

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 10.1
Material contract
Exhibit 10.2
Material contract
Exhibit 10.3
Material contract
Exhibit 10.4
Material contract
Exhibit 10.5
Material contract
Exhibit 10.6
Material contract
Exhibit 10.7
Material contract
Exhibit 10.8
Material contract
Exhibit 10.9
Material contract
Exhibit 10.10
Material contract
  • Signs a material agreement (1.01)
  • Sells unregistered shares (3.02)
  • Reports a change in control (5.01)
  • Reports an executive or board change (5.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Homology Medicines files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Kiora Pharmaceuticals KPRX public float $10M, Jun 30, 2025
  2. Brainstorm Cell Therapeutics BCLI public float $10M, Jun 30, 2025
  3. Scienture Holdings SCNX public float $10M, Jun 30, 2025
  4. LeonaBio ATHA public float $10M, Jun 30, 2025
  5. Mannatech MTEX public float $10M, Jun 30, 2025